Trial · NCT04229264
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
NCT04229264, Phase 3, Unknown, Science Valley Research Institute
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. Trials, record NCT04229264. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04229264
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
- NCT number
- NCT04229264
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Science Valley Research Institute
- Conditions
- Critical Limb Ischemia
- Interventions
- Apixaban, ASA, Clopidogrel 75mg
- First posted
- 2020-01-18
- Last updated
- 2021-04-20
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Restenosis of the treated infrapopliteal artery | 12 months | Number of patients with absence of flow or \>2.4 sistolic index obtained by Duplex Scan |
| Primary | Major amputation | 12 months | Number of patients who underwent amputation of the leg above the ankle |
| Primary | Clinical driven-target lesion revascularization | 12 months | Number of patients who was submitted by reintervention of the treated infrapopliteal artery based on the clinical status |
| Primary | Major cardiovascular events | 12 months | Number of patients who present one of those: myocardial infarction, stroke and cardiovascular death |
| Secondary | Bleeding | 12 months | Number of patients who present major bleeding (MB) or clinically relevant non-major bleeding, using the ISTH criteria |
| Secondary | Healing | 12 months | Time to total healing measured by the Imitomeasure program. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers51
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04229264
GET https://conductscience.org/api/trials/v1/NCT04229264/papers?page=2